Pandemic telehealth flexibilities for buprenorphine treatment: A synthesis of evidence and policy implications for expanding opioid use disorder care in the U.S.  Krawczyk N, Rivera BD, King C, Dooling BCE.  medRxiv [Preprint]. 2023 Mar…

Association of Receipt of Opioid Use Disorder–Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.  Jones CM, Shoff C, Blanco C, Los…

"You'll come in and dose even in a global pandemic": A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic.  Conway A, Treloar C, Crawford S, Degenhardt L, Dore GJ, Farrell M, Hayllar J, Grebely J, Mar…

Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19.  Poulsen MN, Santoro W, Scotti R, Henderson C, Ruddy M, Colistra A.  J Addict Med. 2023 Mar-Apr 01;17(2):e…

Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy Krawczyk, Noa et al. The Lancet Public Health, Volume 8, Issue 3, e238 - e246  https://www.thelancet…

Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study. Suarez E , Jr, Bartholomew TS, Plesons M, Ciraldo K, Ostrer L, Serota DP…